{"id":740714,"date":"2023-03-16T08:35:45","date_gmt":"2023-03-16T12:35:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/"},"modified":"2023-03-16T08:35:45","modified_gmt":"2023-03-16T12:35:45","slug":"bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/","title":{"rendered":"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023"},"content":{"rendered":"
\n

DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d),<\/a> a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2022 before the market opens on Thursday, March 30, 2023. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.<\/p>\n

To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call.<\/p>\n

A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company’s website at https:\/\/ir.bioventus.com\/<\/a>. The webcast will be archived at the same site and available for replay until March 29, 2024.<\/p>\n

\n About Bioventus<\/strong>
\n
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com<\/a> and follow the Company on LinkedIn<\/a> and Twitter<\/a>. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.<\/p>\n

\n Investor and Media Inquiries:<\/strong>
\n
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2022 before the market opens on Thursday, March 30, 2023. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company’s website at https:\/\/ir.bioventus.com\/. The webcast … <\/p>\n

Continue reading “Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740714","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2022 before the market opens on Thursday, March 30, 2023. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company’s website at https:\/\/ir.bioventus.com\/. The webcast … Continue reading "Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T12:35:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023\",\"datePublished\":\"2023-03-16T12:35:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/\",\"name\":\"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=\",\"datePublished\":\"2023-03-16T12:35:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/","og_locale":"en_US","og_type":"article","og_title":"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","og_description":"DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2022 before the market opens on Thursday, March 30, 2023. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company’s website at https:\/\/ir.bioventus.com\/. The webcast … Continue reading \"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-16T12:35:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023","datePublished":"2023-03-16T12:35:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/","name":"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=","datePublished":"2023-03-16T12:35:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTM5OCM1NDY0ODc2IzIwMjkxMTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2022-financial-results-on-march-30-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740714"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740714\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}